New Meds and Tech: Burosumab Twza (Crysvita – Ultragenyx Pharmaceuticals)

Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast…

Read More

New Meds and Tech: Semglee

Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…

Read More

New Meds and Tech: Freestyle Libre 2

Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system.…

Read More

New Meds and Tech: Riomet ER™

Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in…

Read More

Child with Suspected Rickets

Primary Care provider guidelines for referral.

Read More

Child with Suspected Klinefelter Syndrome

Primary Care provider guidelines for referral.

Read More

Infant with Suspected Hyperthyroidism

Primary Care provider guidelines for referral.

Read More

Infant with Suspected Congenital Hypothyroidism

Primary Care provider guidelines for referral.

Read More

Child with Suspected Hyperglycemia

Primary Care provider guidelines for referral.

Read More

Child with Suspected Adrenal Insufficiency

Primary Care provider guidelines for referral.

Read More